Skip to main content

. 1996 Oct;61(4):418. doi: 10.1136/jnnp.61.4.418-a

High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis.

C Nos, M Comabella, M Tintoré, J Rio, A Codina, X Montalban, A Rovira

PMCID: PMC486589 PMID: 8890786

418

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Miller D. H., Rudge P., Johnson G., Kendall B. E., Macmanus D. G., Moseley I. F., Barnes D., McDonald W. I. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain. 1988 Aug;111(Pt 4):927–939. doi: 10.1093/brain/111.4.927. [DOI] [PubMed] [Google Scholar]
Miller D. H., Thompson A. J., Morrissey S. P., MacManus D. G., Moore S. G., Kendall B. E., Moseley I. F., McDonald W. I. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. J Neurol Neurosurg Psychiatry. 1992 Jun;55(6):450–453. doi: 10.1136/jnnp.55.6.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
Milligan N. M., Newcombe R., Compston D. A. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry. 1987 May;50(5):511–516. doi: 10.1136/jnnp.50.5.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
Soukop W., Tschabitscher H. Gammaglobulintherapie bei Multipler Sklerose (MS). Theoretische Uberlegungen und erste klinische Erfahrungen mit 7S-Immunglobulinen in der MS-Therapie. Wien Med Wochenschr. 1986 Sep 30;136(18):477–480. [PubMed] [Google Scholar]
Yan J., Richert J. R., Sirdofsky M. D. High-dose intravenous immunoglobulin for multiple sclerosis. Lancet. 1990 Sep 15;336(8716):692–692. doi: 10.1016/0140-6736(90)92188-n. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES